| Name | Title | Contact Details |
|---|---|---|
Stephanie Licata |
VP, Program Leadership & Portfolio Management | Profile |
Cellanyx has developed proprietary live tumor cell phenotypic biomarker tests to improve cancer risk-stratification and allow informed clinical decision making. The Companys unique approach provides quantitative and actionable information based on analysis of thousands of live tumor cells. The Companys tests employ a microfluidic platform combined with machine vision and machine learning approaches to analyze phenotypic morphological, biochemical and biophysical markers. Cellanyx has demonstrated initial clinical proof-of-concept with its lead phenotypic test in prostate cancer. The initial clinical proof-of-concept study was conducted to demonstrate improved risk stratification in men with low and intermediate Gleason grade (6 and 7) disease and reduce the number of repeat biopsies. Furthermore, analysis of field samples (away from the suspicious core) demonstrated the potential value of Cellanyx phenotypic test as it was able to analyze the tumor microenvironment conditions and predict expected adverse pathology from samples that were not taken from the suspicious core. These new findings from the Cellanyx prostate test are transformative as it will reduce the errors in diagnosing cancers early due to sampling heterogeneity of prostate biopsies.
GI Pathology PLLC is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Memphis, TN. To find more information about GI Pathology PLLC, please visit www.gipath.com
Seattle based Littlebird believes that building better connections and providing greater communication will lead to better results for you, your caregiver, and child. Littlebird`s state-of-the-art wearable device connects parents with their child anywhere, anytime, with on-demand information about who they are with, where they are located, what they are doing, and how they are feeling. Littlebird`s innovative technology and secure digital platform offers parents unique insights into their child`s safety, health and overall well-being. Littlebird`s 24/7 GPS and cellular connectivity enables up-to-date notifications regarding your child`s location, which "approved" caregiver they are with and what they are doing. Littlebird also provides key metrics regarding your child`s heartrate, daily activity, sleep patterns and much more so you can better understand your child`s specific needs. The intuitively designed app also provides a private chat with photo capabilities connecting you and your caregiver(s) so you never miss a moment of your toddler`s day.
Aatru Medical, LLC (Aatru) is a privately-held medical device company specializing in technology development in negative pressure wound therapy for surgical incisions and chronic wounds. The Aatru NPSIMS™ represents a new and advanced technology in ultraportable devices that are designed for use on closed surgical incisions that produce low exudate.
IMX Medical Management Services is a Bala Cynwyd, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.